Our Inherited Disease Panel tests over 300 genes applicable to over 700 unique inherited diseases, including neuromuscular, cardiovascular, developmental, and metabolic diseases. This screening test can be used for preconception testing of prospective parents to screen for potential overlapping genetic disorders as well as diagnosis of inherited conditions.

This test screens for mutations in 17 genes that can cause early onset dementia. The results from this screening test can aid in diagnosis, provide additional information to an already diagnosed patient and identify potential risk genes causing dementia in the family.

This exciting panel tests for 24 carefully selected DNA regions that can predict both hair and eye colour. Our Phenotype panel is capable of simultaneously predicting both the eye and hair colour of a person from DNA via assessment of carefully selected DNA markers.

Autism is a lifelong condition that belongs to a group of neurodevelopmental disabilities known as Autism Spectrum Disorders (ASDs). Our Autism screening Panel analyses over 230 genes associated with ASD and can aid in diagnosis of patients with suspected ASDs. For many children and adults, the everyday life can be significantly improved by a diagnosis and appropriate specialist support.

Establish your genetic risk of hereditary cancers. We offer a cancer panel test which will look for a total of 92 mutations associated with hereditary cancers. The genetic predisposition test for cancer is a powerful tool that can help you reduce your risks or undertake measures that will help you detect any cancers as early as possible.

Cystic fibrosis is a condition which mainly affects the lungs and pancreas, but can affect other parts of the body, including the liver, nose and sinuses, reproductive organs, and sweat glands. Our Cystic Fibrosis testing is performed using massive parallel sequencing (next generation sequencing) which allows for the analysis of exons, intron-exon boundaries, and UTRs that contain common mutations in the CFTR gene. This methodology with sequence analysis of all exons, intron/ exon borders, promoter regions, and specific intronic regions detects more than 98% of CFTR mutations.

Noonan syndrome is a condition that affects 1 in 1000-2500 individuals. Symptoms can include characteristic facial features, heart abnormalities, short stature and intellectual disability. Our Noonan Panel can aid in diagnosis of patients with Noonan-like clinical features or to clarify the genetic risk for individuals with a family history of Noonan syndrome.

Folate deficient? This test screens for the two most common MTHFR gene mutations that can be involved in reduced folate metabolism and/or elevated blood homocysteine levels.